TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/24 18:00 | 8/20/24 | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | S.d | -5 | 1.23 | 0 | -4 | -3 | 131 | D | ||||||||||||||
3/21/24 16:41 | 3/19/24 | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | S | -11 | 2.09 | 0 | -5 | -4 | 118 | D | ||||||||||||||
12/22/23 16:11 | 12/20/23 | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | S | -6 | 1.38 | 0 | -4 | -4 | 98 | D | ||||||||||||||
9/22/23 19:12 | 9/22/23 | CTMX | Cytomx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | S | -7 | 1.30 | 0 | -5 | -6 | 81 | D | ||||||||||||||
3/20/23 18:43 | 3/16/23 | CTMX | Cytomx Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | S | -4 | 1.98 | 0 | -2 | -3 | 71 | D | |||||||||||||||
7/21/22 16:10 | 7/20/22 | CTMX | Cytomx Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | S | -8 | 1.42 | 0 | -6 | -11 | 44 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |